Grapefruitsalso include in their composition not just lycopene but alsoflavonoids, with several benefits, such as the anti-inflammatoryand anti-atherogenic effect, improving vascular reactivity,reducing insulin resistance, decreasing arterial stiffness, LDLcholesterol, and blood pressure (Habauzit et al., 2015). Thesesynergistic effects hamper assessment of quantitative andqualitative effects of lycopene as a dietary factor.Several studies included healthy participants or subjectswith different disorders and cardiovascular risk factors (Konget al., 2010; Thies et al., 2012; Gajendragadkar et al., 2014).Enrolling volunteers with established elevated risk markersfor cardiovascular disorders may increase the probability ofdetecting changes, especially in short time studies (Thies et al.,2012). Also, several other uncontrolled or unidentified lifestylefactors or dietary constituents associated with cardiovasculardisorders, may provide alternative explanations for the differentstudy results (Sesso et al., 2003). Genetic factors remainunconsidered at all in all of the reviewed publications, althoughthey are reported to strongly influence circulating concentrationsof lycopene in different ethnicities (Zubair et al., 2015).Furthermore, plasma, adipose, and dietary carotenoids are notsufficiently correlated to be interchangeably (Sesso et al., 2003).FUTURE RESEARCH DIRECTIONSMost of the studies considered only tomatoes and tomatoproducts as lycopene source. It will be the aim of futurehuman intervention studies to include other lycopene containingfruits such as watermelon, papaya, red grapefruits, and guava,and consider synergistic effects with other components andtheir importance in primary and secondary cardiovascularprophylaxis.Frontiers in Pharmacology | www.frontiersin.org May 2018 | Volume 9 | Article 521115Mozos et al. Lycopene and Vascular HealthBenefits of lycopene should be especially considered inpatients with high cardiovascular risk, statin intolerance,borderline hypertension, aspirin resistance, hyperactive platelets,vascular inflammatory diseases, metabolic syndrome andcoronary heart disease, and its inclusion in combinationtherapies for the mentioned disorders, should be approached.Further mechanistic research is needed to identify new targetsfor prevention and complementary treatment of cardiovasculardisorders.CONCLUSIONSThe present review supports the importance of lycopene inimproving vascular function and in the primary and secondaryprevention of cardiovascular disorders. The demonstrated effectsof lycopene in view of cardiovascular health comprise its generalantioxidant and anti-inflammatory abilities, the antiplatelet, anti-apoptotic and antihypertensive properties, the ability to improveendothelial function, the metabolic profile and ventricularremodeling, reduction of arterial stiffness as well as reductionof size of atherosclerotic plaque. Lycopene exerts favorableeffects in patients with subclinical atherosclerosis, metabolicsyndrome, hypertension, peripheral vascular disease, and severalother cardiovascular disorders, but sometimes conflicting resultswere obtained. Clearly, more and better-designed studies will benecessary to improve our understanding of the positive effectsof lycopene on vascular health and to elucidate the involvedmechanisms on a molecular level.Future cardiovascular disease prevention strategies mightinclude lycopene-enriched products, lycopene supplementationand new combinations including lycopene. Future studiesfocused on dietary lycopene and its synergistic effects withother dietary components in different study populations, withelevated cardiovascular risk, are highly warranted and mightenable development of functional foods useful in prevention andcomplementary treatment of cardiovascular disorders.AUTHOR CONTRIBUTIONSIM is the author of the first draft of the manuscript. DS, AC, CM,JH, and AA contributed toward revising the paper and agree tobe accountable for all aspects of the work. All authors agreed onthe finally submitted version of the manuscript.ACKNOWLEDGMENTSThe authors acknowledge the support by the Polish KNOW(Leading National Research Centre) Scientific ConsortiumHealthy Animal--Safe Food, decision of Ministry of Science andHigher Education No. 05-1/KNOW2/2015.REFERENCESAbdel-Daim, M. M., Eltaysh, R., Hassan, A., and Mousa, S. A. (2018). Lycopeneattenuates tulathromycin and diclofenac sodium-induced cardiotoxicity inmice. Int. J. Mol. Sci. 19:e344. doi: 10.3390/ijms19020344Abushouk, A. I., Ismail, A., Salem, A. M. A., Afifi, A. M., and Abdel-Daim, M. M. (2017). Cardioprotective mechanisms of phytochemicals againstdoxorubicin-induced cardiotoxicity. Biomed. Pharmacother. 90, 935-946.doi: 10.1016/j.biopha.2017.04.033Agarwal, S., and Rao, A. V. (2000). Tomato lycopene and its role in human healthand chronic diseases. Can. Med. Assoc. J. 163, 739-744.Ahn, J., Lee, H., Jung, C. H., and Ha, T. (2012). Lycopene inhibits hepaticsteatosis via microRNA-21-induced downregulation of fatty acid-bindingprotein 7 in mice fed a high-fat diet. Mol. Nutr. Food Res. 56:1665-1674.doi: 10.1002/mnfr.201200182Ahuja, K. D., Pittaway, J. K., and Ball, M. J. (2006). Effects of olive oil and tomatolycopene combination on serum lycopene, lipid profile, and lipid oxidation.Nutrition 22, 259-265. doi: 10.1016/j.nut.2005.07.015Aman, U., Vaibhav, P., and Balaraman, R. (2012). Tomato lycopene attenuatesmyocardial infarction induced by isoproterenol: electrocardiographic,biochemical and anti-apoptotic study. Asian Pac. J. Trop. Biomed. 2, 345-351.doi: 10.1016/S2221-1691(12)60054-9Anjos Ferreira, A. L., Russell, R. M., Rocha, N., Placido Ladeira, M. S., FaveroSalvadori, D. M., Oliveira Nascimento, M. C., et al. (2007). Effect of lycopeneon doxorubicin-induced cardiotoxicity: an echocardiographic, histologicaland morphometrical assessment. Basic Clin. Pharmacol. Toxicol. 101, 16-24.doi: 10.1111/j.1742-7843.2007.00070.xAtanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E. M., Linder, T., Wawrosch,C., Uhrin, P., et al. (2015). Discovery and resupply of pharmacologicallyactive plant-derived natural products: a review. Biotechnol. Adv. 33, 1582-1614.doi: 10.1016/j.biotechadv.2015.08.001Bae, J. W., and Bae, J. S. (2011). Barrier protective effects of lycopene in humanendothelial cells. Inflamm. Res. 60:751-758. doi: 10.1007/s00011-011-0330-9Bansal, P., Gupta, S. K., Ojha, S. K., Nandave, M., Mittal, R., Kumari, S.,et al. (2006). Cardioprotective effect of lycopene in the experimental modelof myocardial ischemia-reperfusion injury. Mol. Cell. Biochem. 289, 1-9.doi: 10.1007/s11010-006-9141-7Basu, A., and Imrhan, V. (2007). Tomatoes versus lycopene in oxidative stress andcarcinogenesis: conclusions from clinical trials. Eur. J. Clin. Nutr. 61, 295-303.doi: 10.1038/sj.ejcn.1602510Belovic, M. M., Girones-Vilaplana, A., Moreno, D. A., Milovanovic, I. L.J., Novakovic, A. R., Karaman, M. A., et al. (2016). Tomato (SolanumLycopersicum L.) processing main product (juice) and by-product (pomace)bioactivity potential measured as antioxidant activity and angiotensin-converting enzyme inhibition. J. Food Process. Preserv. 40, 1229-1237.doi: 10.1111/jfpp.12707Blum, A., Monir, M., Khazim, K., Peleg, A., and Blum, N. (2007). Tomato-rich(Mediterranean) diet does not modify inflammatorymarkers.Clin. Invest. Med.30, E70-E74. doi: 10.25011/cim.v30i2.982Bohm, V. (2012). Lycopene and heart health. Mol. Nutr. Food Res. 56, 296-303.doi: 10.1002/mnfr.201100281Burton-Freeman, B., and Sesso, H. D. (2014). Whole food versus supplement:comparing the clinical evidence of tomato intake and lycopenesupplementation on cardiovascular risk factors. Adv. Nutr. 5, 457-485.doi: 10.3945/an.114.005231Burton-Freeman, B., Talbot, J., Park, E., Krishnankutty, S., and Edirisinghe,I. (2012). Protective activity of processed tomato products on postprandialoxidation and inflammation: a clinical trial in healthy weight men and women.Mol. Nutr. Food Res. 56, 622-631. doi: 10.1002/mnfr.201100649Cavalcante, J. L., Lima, J. A., Redheuil, A., and Al-Mallah, A. H. (2011). Aorticstiffness: current understanding and future directions. J. Am. Coll. Cardiol. 57,1511-1522. doi: 10.1016/j.jacc.2010.12.017Chen, L. P., He, S. Y., Zheng, H., and Dai, Y. L. (2010). Effects and mechanismsof lycopene on the proliferation of vascular smooth muscle cells. Chin. J. Nat.Med. 8, 218-222. doi: 10.3724/SP.J.1009.2010.00218Cheng, H. M., Koutsidis, G., Lodge, J. K., Ashor, A. W., Siervo, M., andLara, J. (2017). Lycopene and tomato and risk of cardiovascular diseases:a systematic review and meta-analysis of epiedemiological evidence.Crit. Rev. Food Sci. Nutr. 11, 1-18. doi: 10.1080/10408398.2017.1362630Frontiers in Pharmacology | www.frontiersin.org May 2018 | Volume 9 | Article 521116Mozos et al. Lycopene and Vascular HealthCooney, M., Cooney, M. T., Maher, V., Khan, B., Leong, T., and Graham, I. (2015).Improvement in the estimation of cardiovascular risk by carotid intima-medialthickness: a report from the Dublin Cardiohealth station study. Prev. Med. Rep.2, 725-729. doi: 10.1016/j.pmedr.2015.08.004Costa-Rodrigues, J., Pinho, O., and Monteiro, P. R. R. (2018). Can lycopene beconsidered an effective protection against cardiovascular disease? Food Chem.245, 1148-1153. doi: 10.1016/j.foodchem.2017.11.055Denniss, S. G., Haffner, T. D., Kroetsch, J. T., Davidson, S. R., Rush, J. W.,and Hughson, R. (2008). Effect of short-term lycopene supplementationand postprandial dyslipidemia on plasma antioxidants and biomarkers ofendothelial health in young, healthy individuals. Vasc. Health Risk Manag. 4,213-222. doi: 10.2147/vhrm.2008.04.01.213Dwyer, J. H., Paul-Labrador, M. J., Fan, J., Shircore, A. M., Merz, C. N., andDwyer, K.M. (2004). Progression of carotid intima-media thickness and plasmaantioxidants: the Los Angeles Atherosclerosis Study. Arterioscler. Thromb.Vasc. Biol. 24, 313-319. doi: 10.1161/01.ATV.0000109955.80818.8aFantin, F., Di Francesco, V., Rossi, A., Giuliano, K., Marino, F., Cazzadori, M.,et al. (2010). Abdominal obesity and subclinical vascular damage in the elderly.J. Hypertens. 28, 333-339. doi: 10.1097/HJH.0b013e328333d23cFigueroa, A., Wong, A., Hooshmand, S., and Sanchez-Gonzalez, M. A. (2013).Effects of watermelon supplementation on arterial stiffness and wavereflection amplitude in postmenopausal women. Menopause 20, 573-577.doi: 10.1097/GME.0b013e3182733794Figueroa, A., Wong, A., Jaime, S. J., and Gonzales, J. U. (2017). Influenceof L-citrulline and watermelon supplementation on vascular function andexercise performance. Curr. Opin. Clin. Nutr. Metab. Care 20, 92-98.doi: 10.1097/MCO.0000000000000340Frederiksen, H., Rasmussen, S. E., Schroder, M., Bysted, A., Jakobsen, J.,Frandsen, H., et al. (2007). Dietary supplementation with an extract oflycopene-rich tomatoes does not reduce atherosclerosis in Watanabe HeritableHyperlipidemic rabbits. Br. J. Nutr. 97, 6-10. doi: 10.1017/S0007114507210153Gajendragadkar, P. R., Hubsch, A., Maki-Petaja, K. M., Serg, M., Wilkinson,I. B., and Cheriyan, J. (2014). Effects of oral lycopene supplementationon vascular function in patients with cardiovascular disease andhealthy volunteers: a randomised controlled trial. PLoS ONE 9:e99070.doi: 10.1371/journal.pone.0099070Gammone, M. A., Riccioni, G., and D'Orazio, N. (2015). Carotenoids:potential allies of cardiovascular health? Food Nutr. Res. 59:26762.doi: 10.3402/fnr.v59.26762Gao, Y., Jia, P., Shu, W., and Jia, D. (2016). The protective effect oflycopene on hypoxia/reoxygenation-induced endoplasmic reticulumstress in H9C2 cardiomyocytes. Eur. J. Pharmacol. 774, 71-79.doi: 10.1016/j.ejphar.2016.02.005Gianetti, J., Pedrinelli, R., Petrucci, R., Lazzerini, G., De Caterina, M., Bellomo,G., et al. (2002). Inverse association between carotid intima-media thicknessand the antioxidant lycopene in atherosclerosis. Am. Heart J. 143, 467-474.doi: 10.1067/mhj.2002.120776Gitenay, D., Lyan, B., Rambeau, M., Mazur, A., and Rock, E. (2007). Comparisonof lycopene and tomato effects on biomarkers of oxidative stress in vitamin Edeficient rats. Eur. J. Nutr. 46, 468-475. doi: 10.1007/s00394-007-0687-2Goff, D. C. Jr, Lloyd-Jones, D. M., Bennett, G., Coady, S., D'Agostino, R. B., sr,Gibbons, R., et al. (2014). 2013 ACC/AHA guideline on the assessment ofcardiovascular risk: a report of the American College of Cardiology/AmericanHeart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol.63(25 Pt B), 2935-2959. doi: 10.1016/j.jacc.2013.11.005Gouranton, E., Thabuis, C., Riollet, C., Malezet-Desmoulins, C., El Yazidi, C.,Amiot, M. J., et al. (2011). Lycopene inhibits proinflammatory cytokineand chemokine expression in adipose tissue. J. Nutr. Biochem. 22, 642-648.doi: 10.1016/j.jnutbio.2010.04.016Habauzit, V., Verny, M. A., Milenkovic, D., Barber-Chamoux, N., Mazur,A., Dubray, C., et al. (2015). Flavanones protect from arterial stiffnessin postmenopausal women consuming grapefruit juice for 6 mo: arandomized, controlled, crossover trial. Am. J. Clin. Nutr.